JPMA sanctions Takeda after manufacturing mix-up
This article was originally published in Scrip
Executive Summary
Japan's main research-based industry grouping, the Japan Pharmaceutical Manufacturers' Association (JPMA), has decided temporarily to suspend Takeda from a vice-president position in response to the firm's violation of the country's Pharmaceutical Affairs Act.